OHSU
Categories | Inventors

Human cytomegalovirus (HCMV) clinical isolate strains

 

OHSU # 1221

Summary:

Technology Overview

Dr. Jay Nelson has a collection of HCMV strains available for licensing as a package or on an individual strain basis. These are all clinical isolates that are at early passage and have not been adapted to any cell type and should therefore retain both endothelial and epithelial cell tropism.

The strains which are available include:

Adinis

Brown

Davis

Dement

Edding

Gerry

Gruden

Harris

Keone

Lacey

Lysistrata

Martinez

New Rock

Phoebe

Powers

Salvo

Schmoe

Simpson

Watkins

These strains are useful for a variety of research applications.

Inventor Profile

Dr. Jay Nelson joined the Oregon Health & Science University as a Professor in the Department of Molecular Microbiology and Immunology in 1992. He was also the Head of Pathobiology and Immunology at the Oregon National Primate Research Center from 1998 to 2000. He is currently the Director of the Vaccine and Gene Therapy Institute and holds joint appointments at the Oregon National Primate Research Center and the Department of Molecular Microbiology and Immunology.

Licensing Opportunity

The strains listed in OHSU #1221 are currently available for non-exclusive licensing as internal research tools. The package of all 19 strains listed above can be licensed as a package through technology OHSU #1121, or individual strains can be licensed through their indivdual technology numbers (OHSU #1121-A, OHSU #1121-B, etc.: see Related Technologies).

Inventors:

Related Technologies:

  • OHSU # 1221-A — Human cytomegalovirus (HCMV) clinical isolate strain: Adinis
  • OHSU # 1221-B — Human cytomegalovirus (HCMV) clinical isolate strain: Brown
  • OHSU # 1221-C — Human cytomegalovirus (HCMV) clinical isolate strain: Davis
  • OHSU # 1221-D — Human cytomegalovirus (HCMV) clinical isolate strain: Dement
  • OHSU # 1221-E — Human cytomegalovirus (HCMV) clinical isolate strain: Edding
  • OHSU # 1221-F — Human cytomegalovirus (HCMV) clinical isolate strain: Gerry
  • OHSU # 1221-G — Human cytomegalovirus (HCMV) clinical isolate strain: Gruden
  • OHSU # 1221-H — Human cytomegalovirus (HCMV) clinical isolate strain: Harris
  • OHSU # 1221-I — Human cytomegalovirus (HCMV) clinical isolate strain: Keone
  • OHSU # 1221-J — Human cytomegalovirus (HCMV) clinical isolate strain: Lacey
  • OHSU # 1221-K — Human cytomegalovirus (HCMV) clinical isolate strain: Lysistrata
  • OHSU # 1221-L — Human cytomegalovirus (HCMV) clinical isolate strain: Martinez
  • OHSU # 1221-M — Human cytomegalovirus (HCMV) clinical isolate strain: New Rock
  • OHSU # 1221-N — Human cytomegalovirus (HCMV) clinical isolate strain: Phoebe
  • OHSU # 1221-O — Human cytomegalovirus (HCMV) clinical isolate strain: Powers
  • OHSU # 1221-P — Human cytomegalovirus (HCMV) clinical isolate strain: Salvo
  • OHSU # 1221-Q — Human cytomegalovirus (HCMV) clinical isolate strain: Schmoe
  • OHSU # 1221-R — Human cytomegalovirus (HCMV) clinical isolate strain: Simpson
  • OHSU # 1221-S — Human cytomegalovirus (HCMV) clinical isolate strain: Watkins

Categories:

For more information, contact:

Trina Voss
Technology Development Manager
503-494-9839

OptionPrice
(terms)  $30000.00
(terms)  $60000.00